Prothena Corp PLC
(FRA:0PT)
€
13.1
-1.2 (-8.39%)
Market Cap: 710.61 Mil
Enterprise Value: 220.07 Mil
PE Ratio: 0
PB Ratio: 1.38
GF Score: 64/100 Prothena Corporation PLC at Jefferies Healthcare Conference Transcript
Jun 08, 2023 / 05:00PM GMT
Release Date Price:
€65
(-3.70%)
Mike Yee
Jefferies - Analyst
All right. Thank you for joining us on the next session here at the Jefferies Healthcare Conference. I'm Mike Yee, Managing Director and senior biotechnology analyst. And I have the pleasure of having the President and CEO of Prothena up here with us, Gene Kinney. Thanks for joining us, Gene.
Gene Kinney
Prothena Corporation plc - President, CEO & Director
Thanks for having us, Mike.
Mike Yee
Jefferies - Analyst
Absolutely. You have done a fantastic job building out a whole portfolio of products, specifically a pipeline of products, particularly around neurodegenerative diseases, protein misfolding, and we'll get to even vaccination as well for neurodegeneration.
Gene Kinney
Prothena Corporation plc - President, CEO & Director
Yup.
Questions & Answers
Mike Yee
Jefferies - Analyst
And so there's a lot to talk about. I would love to just start off first by asking about your
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot